Yu R - Search Results

1

Phase II trial of antiepidermal growth factor receptor antibody C225 in patients with advanced renal cell carcinoma.

Motzer RJ, Amato R, Todd M, Hwu WJ, Cohen R, Baselga J, Muss H, Cooper M, Yu R, Ginsberg MS, Needle M. Motzer RJ, et al. Among authors: yu r. Invest New Drugs. 2003 Feb;21(1):99-101. doi: 10.1023/a:1022928612511. Invest New Drugs. 2003. PMID: 12795534 Clinical Trial.

2

Phase II trial of thalidomide for patients with advanced renal cell carcinoma.

Motzer RJ, Berg W, Ginsberg M, Russo P, Vuky J, Yu R, Bacik J, Mazumdar M. Motzer RJ, et al. Among authors: yu r. J Clin Oncol. 2002 Jan 1;20(1):302-6. doi: 10.1200/JCO.2002.20.1.302. J Clin Oncol. 2002. PMID: 11773183 Clinical Trial.

3

Phase II trial of arsenic trioxide in patients with metastatic renal cell carcinoma.

Vuky J, Yu R, Schwartz L, Motzer RJ. Vuky J, et al. Among authors: yu r. Invest New Drugs. 2002 Aug;20(3):327-30. doi: 10.1023/a:1016270206374. Invest New Drugs. 2002. PMID: 12201495 Clinical Trial.

4

Phase I trial of 40-kd branched pegylated interferon alfa-2a for patients with advanced renal cell carcinoma.

Motzer RJ, Rakhit A, Ginsberg M, Rittweger K, Vuky J, Yu R, Fettner S, Hooftman L. Motzer RJ, et al. Among authors: yu r. J Clin Oncol. 2001 Mar 1;19(5):1312-9. doi: 10.1200/JCO.2001.19.5.1312. J Clin Oncol. 2001. PMID: 11230473 Clinical Trial.

5

Phase II trial of irofulven (6-hydroxymethylacylfulvene) for patients with advanced renal cell carcinoma.

Berg WJ, Schwartz L, Yu R, Mazumdar M, Motzer RJ. Berg WJ, et al. Among authors: yu r. Invest New Drugs. 2001;19(4):317-20. doi: 10.1023/a:1010609810517. Invest New Drugs. 2001. PMID: 11561691 Clinical Trial.

6

Phase I clinical/pharmacokinetic and pharmacodynamic trial of the c-raf-1 antisense oligonucleotide ISIS 5132 (CGP 69846A).

Stevenson JP, Yao KS, Gallagher M, Friedland D, Mitchell EP, Cassella A, Monia B, Kwoh TJ, Yu R, Holmlund J, Dorr FA, O'Dwyer PJ. Stevenson JP, et al. Among authors: yu r. J Clin Oncol. 1999 Jul;17(7):2227-36. doi: 10.1200/JCO.1999.17.7.2227. J Clin Oncol. 1999. PMID: 10561280 Clinical Trial.

7

Dose ranging pharmacokinetic trial of high-dose alicaforsen (intercellular adhesion molecule-1 antisense oligodeoxynucleotide) (ISIS 2302) in active Crohn's disease.

Yacyshyn BR, Barish C, Goff J, Dalke D, Gaspari M, Yu R, Tami J, Dorr FA, Sewell KL. Yacyshyn BR, et al. Among authors: yu r. Aliment Pharmacol Ther. 2002 Oct;16(10):1761-70. doi: 10.1046/j.1365-2036.2002.01341.x. Aliment Pharmacol Ther. 2002. PMID: 12269969 Free article. Clinical Trial.

8

A Mucous Permeable Local Delivery Strategy Based on Manganese-Enhanced Bacterial Cuproptosis-like Death for Bacterial Pneumonia Treatment.

Hua S, Hu H, Liu J, Lu F, Yu R, Zhang X, Sun H, Wang Z, Li Y, Xia J, Xu F, Zhou M. Hua S, et al. Among authors: yu r. ACS Nano. 2024 Nov 7. doi: 10.1021/acsnano.4c09695. Online ahead of print. ACS Nano. 2024. PMID: 39506631

9

Molecular identification and expression patterns of sweet cherry HIPPs and functional analysis of PavHIPP16 in cold stress.

Yu R, Hou Q, Deng H, Xiao L, Liu K, Wu Y, Qiao G. Yu R, et al. Planta. 2024 Nov 6;260(6):134. doi: 10.1007/s00425-024-04567-z. Planta. 2024. PMID: 39505755

10

The Expression Levels of Transforming Growth Factor β1 and Tumor Necrosis Factor Receptor Associated Factor 6 in Allergic Rhinitis Patients and Their Potential Relationship with Epithelial - Mesenchymal Transition: A Pilot Prospective Observational Study.

Wang K, Gao Q, Bai Y, Yu R, Luo Q. Wang K, et al. Among authors: yu r. J Asthma Allergy. 2024 Nov 1;17:1083-1092. doi: 10.2147/JAA.S474445. eCollection 2024. J Asthma Allergy. 2024. PMID: 39502932 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,870 results

Search Page

Filters